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Abstract
Objectives. The immunologic events that build up to the fatal
neurological stage of experimental cerebral malaria (ECM) are
incompletely understood. Here, we dissect immune cell behaviour
occurring in the central nervous system (CNS) when Plasmodium
berghei ANKA (PbA)-infected mice show only minor clinical signs.
Methods. A 2-photon intravital microscopy (2P-IVM) brain imaging
model was used to study the spatiotemporal context of early
immunological events in situ during ECM. Results. Early in the
disease course, antigen-specific CD8+ T cells came in contact and
arrested on the endothelium of post-capillary venules. CD8+ T cells
typically adhered adjacent to, or were in the near vicinity of,
perivascular macrophages (PVMs) that line post-capillary venules.
Closer examination revealed that CD8+ T cells crawled along the
inner vessel wall towards PVMs that lay on the abluminal side of
large post-capillary venules. ‘Activity hotspots’ in large post-
capillary venules were characterised by T-cell localisation, activated
morphology and clustering of PVM, increased abutting of post-
capillary venules by PVM and augmented monocyte accumulation.
In the later stages of infection, when mice exhibited neurological
signs, intravascular CD8+ T cells increased in number and changed
their behaviour, actively crawling along the endothelium and
displaying frequent, short-term interactions with the inner vessel
wall at hotspots. Conclusion. Our study suggests an active
interaction between PVM and CD8+ T cells occurs across the
blood–brain barrier (BBB) in early ECM, which may be the
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initiating event in the inflammatory cascade leading to BBB
alteration and neuropathology.
Keywords: CD8+ T cells, perivascular macrophage, malaria, immune
response, 2-photon intravital microscopy
INTRODUCTION
Cerebral malaria (CM) is a life-threatening
complication of malaria that takes a significant
toll on human life each year.1 Despite many years
of research, effective malaria vaccines are not
available and parasite resistance to drugs is
common,2 which highlights the need for a better
understanding of CM pathogenesis.3,4 Detailed
examination of the complex pathophysiologic
processes leading to neurological disease in
individuals infected with P. falciparum, the
pathogen responsible for causing CM, cannot be
conducted in humans,5 necessitating the need for
small animal models. In this context, the murine
PbA-infected ECM model is widely used, as it
reproduces many features of human CM.6 The
model has proven particularly useful for
investigating the inflammatory and pathological
processes that result in neurological disease
during malaria infections.7–10 Several studies have
demonstrated the indispensable role for CD8+ T
cells in ECM pathogenesis.11,12 However, their
precise activities locally within the cerebral
vasculature that contributes to neurological
disease have only recently been investigated.13
Parasite-specific CD8+ T cells are initially
stimulated by dendritic cells (DCs) in the spleen,12
which then migrate to the brain guided by the
chemokine CXCL10 (IP-10).14,15 Brain-infiltrating
CD8+ T cells alter endothelial BBB function,
promote leucocyte sequestration and eventually
cause neurological disease.16,17 Mice deficient in
granzyme B and perforin are completely
protected against ECM reinforcing the belief that
neurological disease is primarily a manifestation
of cytotoxic T lymphocyte (CTL)-mediated tissue
damage.18–20 Some evidence indicates that CTL
requires an additional antigenic stimulus locally
within the brain in order to release their cytotoxic
enzymes18 and that endothelial cells (ECs) provide
this stimulus via MHC class I-mediated parasite
antigen presentation.13 However, reporter mice
that reveal professional antigen-presenting cell
(APC) populations were not used in this in vivo
study, despite previous reports showing that
antigen-specific CD8+ T cells make long-lasting
contact with CNS-resident CX3CR1
+ APC in the
perivascular space.21 Nevertheless, the role of
CX3CR1
+ APC in ECM itself is not entirely clear as
functional studies have relied on clodronate–
liposome depletion of the cells,21 which causes
non-specific inflammation and an influx of
myeloid cells even in the absence of infection.
Studies examining the behaviour of T cells
in situ in the brain require advanced microscopy
technology and fluorescent reporter mouse strains
to allow for tracking of their interactions with the
endothelium or CNS-resident cell populations.22
For example, using such approaches, seminal
studies in the multiple sclerosis mouse model
experimental autoimmune encephalomyelitis
(EAE) have shown that circulating CD4+ T cells
expressing a4-integrins arrest to the vascular
endothelium and then transmigrate through the
tight junctions of the BBB into the perivascular
space.23 The perivascular space is akin to a castle
moat bordered by an outer wall, the BBB, and an
inner wall, the glia limitans, formed by astrocyte
end processes.24 Within this space, APCs such as
PVM and DC reside, where they act as
‘gatekeepers’ for parenchymal leucocyte
invasion.25–27 PVMs play a multifaceted role in
diseases such as multiple sclerosis, Alzheimer’s
disease, type 1 diabetes and cancer.28 PVM and
microglia continually survey the CNS
microenvironment with motile cellular processes
and respond to BBB disruption by surrounding the
affected vasculature.29,30 In line with this, trans-
endothelial penetration of inter-endothelial
junctions by macrophages has been reported in
the dermis, mesentery and brain.31–33 Process
extensions of PVM also monitor the kidney
vasculature.32–34 Filopodia of macrophages have
been reported to localise to inter-endothelial
junctions and bridge neighbouring tip cells in the
embryonic mouse brain.35,36 Thus, PVM and EC
form an inter-dependent, reciprocal vascular unit
that supports angiogenesis, macrophage
differentiation and integrity of EC junctions.34,36
In this context, microglial activation during ECM
has been reported.37,38 Upon transmigration into
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the perivascular space, T cells may re-encounter
cognate antigen presented on PVM23 that may or
may not involve T-cell receptor (TCR)
engagement.39,40 In this context, studies in human
postmortem CM samples have shown that blood
vessels are stacked with leucocytes including
monocytes, macrophages and T cells.41,42
T-cell entry into the brain during ECM has been
recorded mostly in the late stages of disease;
therefore, it remains unclear how T cells behave
in the early phase of infection, in particular where
and how they initially encounter cognate antigen
in the CNS.13,21 Using our 2P-IVM brain imaging
model,43 we have previously demonstrated that
CD8+ T effector cells promote monocyte
accumulation in the cerebral vasculature 1–2 days
prior to the onset of the neurological stage (NS)
of ECM.17 In this study, we explored the precise
behaviour of T cells with particular emphasis on
early-stage disease. We found that polyclonal
CD8+ T cells isolated from PbA-infected mice
specifically localised at activity hotspots defined
by PVM along the vasculature. Our data indicate
that these early PVM-T cell localisations may
represent the initial event that kick-starts the
inflammatory cascade culminating in T-cell
extravasation and ECM.
RESULTS
GFP+ T cells undergo a profound
transformation in behaviour and function
across the different disease stages of ECM
In order to track T cells in the brain during
different stages of ECM, we made use of the
transgenic DPE-GFP reporter mice post-PbA
infection (Figure 1a–c).44,45 In these mice, GFP
expression is driven under the control of the
distal and proximal Cd4 enhancers and
promoters. All ab T cells and PVM in these mice
express GFP, with PVM being distinguishable
from T cells based on high levels of GFP
expression, behaviour and morphology.45 DPE-
GFP and DPE-GFPxRAG-1/ mice were infected
with PbA and monitored daily for clinical signs
up to and including day 7 p.i., when most
immune-competent animals develop NS
(Figure 1a–c). Approximately 90% of the PbA-
infected DPE-GFP mice developed minor clinical
signs on day 5–6 p.i., which was thus defined as
early-stage (ES) disease. NS developed on day 7
p.i. with mice typically showing loss of motor
response. As expected, DPE-GFPxRAG-1/ control
mice were completely protected from ECM, thus
confirming the essential role of the adaptive
immune system (Figure 1a, c). Flow cytometric
analysis of brain-sequestered leucocytes (BSL)
confirmed the large increase in CD8+CD44hiGFP+
T-cell numbers in the CNS during ECM (Figure 1d,
e). Consistent with previous studies, CD8GFP+ T
cells also increased significantly, but their
absolute numbers were lower than their CD8+
counterparts (Figure 1e).14,17
We next performed 2P-IVM in PbA-infected
DPE-GFP mice during the various stages of ECM
development (Figure 1f–h). A distinct population
of large, dendritic-shaped GFP+ perivascular cells
(indicated by pink arrows) lined post-capillary
venules (PCVs) in DPE-GFP mice. These cells
expressed the myeloid/macrophage markers F4/80,
CD11b and CD64 (Figure 1i–k) and represented
PVM as reported previously in the skin ([45] and
see further below). Flow cytometric analysis
confirmed that PVMs were CD45+GFP+
CD90CD3CD11b+F4/80+ (Supplementary figure 1a)
and could be distinguished from microglia that
were CD45intGFPCD90CD3CD11b+F4/80 (green
outline).45 GFP+ PVMs were easily distinguishable
from the smaller spherical GFP+ T cells in the
blood vessels (indicated by white arrows,
Figure 1g). Rolling, crawling and arrested T-cell
behaviour is defined elsewhere (see Methods).46–51
In uninfected (UI) mice, very few GFP+ T cells were
observed to interact with the endothelium of PCV
as would be expected in the steady state
(Figure 1f, l).52 Mice in ES showed GFP+ T cells
sporadically arresting to the endothelium of PCV.
A 10-fold increase in the average number of T cells
(187  28 mm2 min1) was recorded compared to
UI mice (Figure 1g, l), with a further 3.9-fold
increase recorded as the disease progressed from
ES to NS (636  89 mm2 min1) (Figure 1h, l;
Supplementary video 1). Of the total GFP+ T cells
that had accumulated in the PCV during ES, 76%
firmly arrested on the inner vessel wall, while the
remaining 24% either rolled or crawled in
approximately equal numbers (Figure 1m). In NS,
the average number of arrested cells remained
unchanged compared to ES, whereas crawling cells
increased significantly with disease progression,
such that of GFP+ cells, 67% of cells crawled, 20%
arrested and 13% rolled along the endothelium
(Figure 1m). These observations are consistent with
reports that T cells crawl vigorously along the
luminal surface of blood vessels prior to their
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Figure 1. CD8+ T cells exhibit distinct motility patterns across different disease stages of ECM. PbA-infected DPE-GFP and DPE-GFPxRAG-1/
mice were monitored for (a) mean clinical score *P < 0.05 (unpaired t-test) or (b) clinical score of individual DPE-GFP mice on days 5–7 p.i.; mice
in ES showed either nil or minor clinical signs and those in NS typically showed loss of motor response. Each symbol in b represents one mouse
(n = 12). (c) % survival, *P < 0.05 (Mantel–Cox test). a–c are from 2 or 5 independent experiments. (d) Flow cytometric analysis shows > 95%
of CD8+ T cells expressed GFP in both healthy UI mice and those that developed NS. (e) Quantitative analysis of brain-sequestered CD8+GFP+ and
CD8GFP+ T cells from 3 or 4 mice/group. Bars represent mean  SEM. *P < 0.05 (ANOVA). (f–h) Representative 2P-IVM snapshots of the
cerebral microvasculature of DPE-GFP mice at various disease stages (n = 3 or 8 mice/group). White arrow in g indicates arrested cells. White
tracks in h indicate crawling cells. Yellow arrows indicate direction of blood flow. Pink arrows indicate GFP+ PVM. Scale bars represent 100 lm in
f, 47 lm in g and 75 lm in h. (i–k) Confocal images of brain sections stained with antibodies against (i) F4/80, (j) CD11b and (k) CD64.
Average number of (l) total and (m) rolling, arrested and crawling GFP+ T cells. Bars represent mean  SEM. ns, not significant, *P < 0.05,
***P = 0.0001, ****P < 0.0001 (Kruskal–Wallis test, Dunn’s test). 26–94 PCVs from 3 or 8 mice/group. e–m are from at least 2 independent
experiments. (n) Mean track velocity of rolling and crawling GFP+ T cells. 36–96 cell tracks from 4 or 8 mice/group, and 2 or 3 independent
experiments. ***P = 0.0001, ****P < 0.0001 (Mann–Whitney U-test).
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extravasation in the build-up to clinical EAE.23
Furthermore, GFP+ cells, similar to monocytes,17
rolled more slowly as the disease progressed from
ES [Vmean: 35  6.7 µm s1] to NS [Vmean:
9.7  1.4 µm s1] (Figure 1n). However, crawling
speed increased from ES [Vmean: 1.3  0.2 µm s1]
to NS [Vmean: 4.0  0.2 µm s1]. Together, our data
show that intravascular GFP+ T cells in DPE-GFP
mice increase in number and display distinct
migratory patterns across the different disease
stages of ECM.
Transferred CD8+GFP+ T cells arrest to the
vascular endothelium and drive the
progression of ES to NS in RAG/ mice
Since we could not unequivocally distinguish
between CD4+ and CD8+ T cells in DPE-GFP mice,
we resorted to our previously published adoptive
transfer approach to investigate the behaviour of
CD8+ T cells (Figure 2a).17 To this end, we
purified CD8+ T cells from the spleen of either UI
control (henceforth termed na€ıve) or PbA-
infected (termed primed) DPE-GFP mice on day 7
p.i. (Figures 2a and Supplementary figure 1b, c).
CD8 splenocytes were also collected from PbA-
infected DPE-GFP mice on day 7 p.i. (termed
primed CD8 Sp). A total of 107 primed CD8+ T
cells or primed CD8 Sp were injected into PbA-
infected DPE-GFPxRAG-1/ recipient mice. Na€ıve
CD8+ T cells from UI DPE-GFP mice served as a
negative control. Recipients of primed CD8 Sp,
na€ıve CD8+ T cells and those that received no
cells presented with only minor clinical signs
during the observation period of 6 days
(Figure 2b). They were mostly free from signs of
illness on day 7 p.i. (Figure 2c). This was
consistent with the reported inability of these
cells to reverse the resistance of RAG-1/ mice
to neurological disease.17,19 In contrast, all mice
that received primed CD8+ T cells exhibited
clinical signs of illness on day 7 p.i. and began to
progress to NS (Figure 2c). We noted that none
of the DPE-GFPxRAG-1/ mice that received
primed CD8+ T cells had a profound impairment
of motor responses typically seen in DPE-GFP
mice during NS (Figure 1b). For quantification
purposes, we therefore pooled recipients of
primed CD8+ T cells into ES regardless of their
disease stage. Quantification by flow cytometry
showed that, compared to UI mice, increased
numbers of CD8+ T cells sequestered in the brains
of DPE-GFPxRAG-1/ mice that had received
primed CD8+ T cells, which is consistent with
previous reports.12,19
We also performed dose titration experiments
using increasing numbers of adoptively
transferred primed CD8+ T cells (0, 10 and
22 9 106) (Supplementary figure 1d). Increasing
the number of cells to 22 9 106 accelerated the
disease course by 1–2 days, and by day 7 p.i., all
the mice had progressed in their disease course
and were euthanised. Taken together, we show
that PbA-specific CD8+GFP+ effector T cells are
capable of promoting the disease course in
immunodeficient mice. The fact that they
accumulate in the CNS during the different
disease stages of ES and NS therefore enabled us
to specifically track their intravascular behaviour.
Next, we adoptively transferred the various cell
populations into PbA-infected DPE-GFPxRAG-1/
mice as depicted in Figure 2a, and 2P-IVM was
performed when mice were in ES. As with DPE-
GFP mice, GFP+ PVM lined PCV in recipient
animals (indicated by pink arrows, Figure 2d).45 As
expected, in mice that received no cells
(0 mm2 min1, Supplementary figure 2a,
Supplementary video 2), primed CD8 Sp
(7.7  7 mm2 min1) and na€ıve CD8+ T cells
(82.5  42 mm2 min1) (Figure 2d, e), GFP+
adherent cells in PCV were either completely
absent or present in low numbers. Alternatively,
mice that received primed CD8+ T cells showed an
increased accumulation of GFP+ adherent cells
(98.5  19 mm2 min1) in the PCV during the ES
phase (indicated by red arrows, Figure 2d, e;
Supplementary video 3). Together, our data show
that CD8+ T cells primed to Plasmodium interact
with the CNS vasculature in significant numbers
24–48 h before they normally induce the
development of NS in mice. At this stage, very
few, if any, T cells leave the vasculature, which
raises the question of whether and where they
see their cognate antigen prior to inducing ECM.
Intravascular CD8+GFP+ T cells localise at
PVM sites
Extravasated CD8+ T cells arrest at CX3CR1
+ APC in
the perivascular space during ECM.21 Strikingly,
we found that some GFP+CD8+ T cells in PbA-
infected DPE-GFP mice crawled along the inner
vessel wall towards GFP+ PVM during ES
(Figure 3a, b; Supplementary video 4). These T
cells exhibited directional migration, crawling
with or against the blood flow or perpendicular
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to the vessel axis to eventually arrive at a site of
GFP+ PVM residence (indicated by red arrows and
inset in Figure 3b; Supplementary video 4). This
behaviour was replicated by primed CD8+ T cells
adoptively transferred into PbA-infected DPE-
GFPxRAG-1/ mice (Supplementary figure 2b;
Supplementary video 5). Other cell types including
primed CD8 Sp or na€ıve CD8+ T cells did not
exhibit interactions with the vascular wall and
rather moved with the blood flow (Figure 2d,
Supplementary video 3). Upon their arrival at PVM
sites, crawling T cells often paused their migration
and assumed a spherical or elongated, non-
polarised morphology (white arrow, Figure 3c, d).
DPE-GFP x RAG-/- recipient DPE-GFP donor 
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Figure 2. Plasmodium-specific CD8+ T cells arrest to the inner wall of PCV during ES. (a) CD8+ T cells or CD8 Sp were MACS-purified from the
spleen of UI (termed na€ıve) or PbA-infected (termed primed) DPE-GFP donor mice on day 7 p.i. and adoptively transferred i.v. into PbA-infected
DPE-GFPxRAG-1/ mice as depicted. Mice that developed NS are shown in blue. (b) Clinical score of individual DPE-GFPxRAG-1/ mice on days
4–6 p.i. Each symbol represents one mouse. Recipients of primed CD8 Sp, na€ıve CD8+ T cell, primed CD8+ T cell and those that received no
cells are shown in white, green, red and grey, respectively. These mice presented with nil or minor clinical signs. (c) The number of signs of
illness on day 7 p.i. Each symbol represents one mouse. (d) 2P-IVM was performed when recipients of primed CD8+ T cells were showing signs
of illness. Representative snapshot of 2 independent experiments (n = 2, 3 or 5 mice/group). Blue represents second harmonic generation (SHG)
signals. Red arrows indicate arrested CD8+GFP+ T cells. White arrows indicate direction of blood flow. Pink arrows indicate GFP+ PVM. Scale bars
represent 100 µm (primed CD8 Sp) and 60 µm (na€ıve and primed CD8+ T). (e) Average number of arrested and crawling GFP+ T cells from 18-
59 PCV. Primed CD8 Sp (n = 2), na€ıve CD8+ T (n = 3) and primed CD8+ T (n = 5) are from 2 independent experiments. Bars represent
mean  SEM. ns, not significant, *P < 0.05, ***P = 0.001, ****P < 0.0001 (Kruskal–Wallis test, Dunn’s test).
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Figure 3. CD8+ T cells co-localise with PVM. (a, b) A time series of the cerebral vasculature of PbA-infected DPE-GFP mice during ES. One of
two independent experiments (n = 2). Yellow arrows indicate direction of blood flow; blue arrows, CD8+ T cells; white lines, migration tracks of
T cells after 10 min; and red arrows, localisation with PVM. Scale bar 60 lm. T cells show discrimination while localising (inset). Panels 1 and 2, T
cell (blue arrow) migrates towards 1st PVM (asterisk). Panel 3, T cell retracts its body and re-orientates towards 2nd PVM (plus symbol). Panels 4
and 5, T cell localises only with 2nd PVM after 10 min. Scale bar 20 lm. (c, d) Single x-y-t focal plane of a primed CD8+ T cell (white arrow)
localised at a PVM site in DPE-GFPxRAG-1/ mice (asterisk indicates PVM). Scale bar 25 lm in (c) and 16 lm in (d). Representative of 5 mice
from 3 independent experiments. (e) Percentage of CD8+ T cells localising at PVM sites. Each symbol represents one mouse (n = 3 or 6). 90–115 T cells
from 44 to 48 PCV, 2 or 3 independent experiments. Error bars represent mean  SEM. ns, not significant, *P < 0.05, **P < 0.005 (unpaired t-test).
(f) % CD8+ T cells localising with PVM. 114, 213 and 162 CD8+ T cells from 18 to 101 PCVs were assessed for ES (primed CD8+ T), ES (nil) and NS,
respectively. ns, not significant, *P < 0.05, **P < 0.001 (one-way ANOVA; Kruskal–Wallis test, comparing % localisation in each group with every other
group). Data are from 2, 3 or 5 (DPE-GFPxRAG-1/) and 3 or 8 (DPE-GFP) mice/group from 2 or 3 independent experiments.
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Closer inspection of the x-y-t single plane showed
that approximately 1/3rd of the GFP+ intravascular
T cells were directly aligned along the inner vessel
wall with GFP+ PVM located on the abluminal side
(Figure 3e; Supplementary video 6). The
proportion of CD8+ T cells that localised at PVM
sites was significantly higher during ES (DPE-GFP
mice, 35.2  5%; primed CD8+ T>DPE-GFPxRAG-
1/, 35.8  12%) and NS (DPE-GFP mice,
55.9  9%) compared to control groups that
included UI DPE-GFP mice (0%) and PbA-infected
DPE-GFPxRAG-1/ mice that received primed
CD8 Sp (0%), na€ıve CD8+ T cells (8.3  8%) or
transferred primed RFP+OT-I effector cells, which
do not have specificity for PbA (0%) (Figure 3f). T
cells that had localised at PVM sites were
immobile (mean distance from PVM: DPE-
GFPxRAG-1/ mice, 8.3  1.3 µm; DPE-GFP mice,
7.2  0.5 µm) (Supplementary figure 2c;
Supplementary video 6).40 T cells that had not
localised at PVM sites rapidly scanned the
endothelial wall (mean distance from PVM: DPE-
GFPxRAG-1/ mice, 17.6  1.7 µm; DPE-GFP mice,
17.1  1.3 µm), displaying an agitated behaviour
as reported for T cells that scan for antigen
expression on the surface of APC.40 Our data
show that Plasmodium-specific CD8+ T cells display
intravascular directional migration and lie directly
adjacent to GFP+ PVM in the early stage of ECM.
Dendritic-shaped GFP+ perivascular APCs are
PVM
GFP+ PVMs were abundant around medium-to-
large (20–160 µm diameter) PCV in the
leptomeninges (Figure 4a and inset) and were
bordered by astrocytes (glia limitans) that line the
perivascular space (Figure 4b).25,29 PVMs were
scarce around arterioles, capillaries and small PCV
(8–20 µm diameter) (Figure 4c, d)16 and were
distinct from DC, as reported.53 In uninfected DPE-
GFP and PbA-infected DPE-GFPxRAG-1/ mice
adoptively transferred with primed CD8 Sp or
na€ıve CD8+ T cells, PVM abutted the PCV as single
cells (Figure 4e, g) pink arrow in 1f, 2d). In
comparison, during the course of ECM, PVM
increased their cell size and moved closer to the
vasculature, thereby covering a greater
percentage of the PCV wall (Figure 4f, h, I; pink
arrow in 1g, h, 2d, Supplementary videos 1, 3).29
Besides residing as single cells, adjacent PVM
grouped together to form clusters, which
increased in cellularity with the progression of
clinical disease (Figure 4e, g). These ‘activity
hotspots’ correlated with the attraction of other
leucocytes and were defined as whole or part of a
blood vessel abutted by PVM that shows
accumulation of ≥ 1 rolling, adherent or crawling
leucocyte. Given that PVMs have a demonstrated
role of leucocyte attraction in infectious models,
this may indicate a similar role in ECM.45
Activity hotspots of PVM create a niche for
CD8+ T cells
Previous reports have shown that perivascular
APCs act as barometers of neuroinflammation,
with perivascular clustering associated with BBB
disruption, fibrinogen leakage and
inflammation.29,33 We found that PVM activity
hotspots were distributed along the length of
large PCV (Figure 5a and inset). Curiously,
arterioles, capillaries and PCV of <20 µm diameter
were mostly free of CD8+ T-cell accumulation and
scarcely surrounded by PVM (Figures 5b, c, 4d). In
this context, it is perhaps relevant that capillaries
and arterioles in the CNS lack a perivascular
space.26 Differential staining of PCV (blue) (upper
left panel), arterioles (dim red) and monocytes
(bright red) (lower left panel) was achieved using
wheat germ agglutinin (WGA) and anti-CD31
antibody treatment (see Methods). PVM activity
correlated with the accumulation of monocytes
(magenta) (upper right panel) and CD8+ T cells
(upper left and lower right panel; yellow arrow in
inset) in PCV, regardless of the disease stage of
ECM. PVM showed an activated morphology
characterised by amoeboid appearance, dextran+
phagosomes and process extensions displaying
reduced complexity and re-orientating towards
the vasculature (Figure 5d, 4i).29 However, inactive
sites in these mice were not different to control
groups, which is consistent with reports that non-
inflamed blood vessels show neither vascular
leakage nor alteration in tight junction protein
expression in mice with fatal disease.13
Quantitative analysis confirmed that increased
perivascular clustering correlated with increased
CD8+ T-cell accumulation during ES (Figure 5e).
We have previously shown that Plasmodium-
primed CD8+ T cells induce monocyte
accumulation in large PCV during ES17; however,
the reporters used in this study revealed other
myeloid cells in the perivascular space in addition
to PVM. 3D rendering of high magnification
images could not resolve the interface between T
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Figure 4. Phenotypic characterisation and distribution of PVM during ECM. (a) Tile scan image of the top of the brain in UI DPE-GFP mice using
confocal microscopy. Scale bar 340 lm. (b) PVM intercalated with GFAP, an intermediate filament protein produced by astrocytes (glia limitans).
Scale bar 110 lm. (c) PVM closely abuts the length of large PCV (blue) but not arterioles (red) or capillaries (red mixed with blue). Scale bar
70 lm. a–c are representative of 2 or 3 independent experiments (n = 3). (d) 2P-IVM of the cerebral vasculature during ES. Grey bars indicate 0,
and black bars ≥ 1 indicate PVM abutting the length of a blood vessel. 171 blood vessels from 4 independent experiments (n = 8). Bars represent
mean  SEM. 2P-IVM was performed on DPE-GFP (e, f) and DPE-GFPxRAG-1/ (g, h) mice. Number of PVM was quantified manually. Clusters
were defined as cell area that is at least twofold more than that of UI mice. Error bars represent mean  SEM. ns, not significant, **P < 0.001,
***P = 0.0001, ****P < 0.0001 (ANOVA, Kruskal–Wallis test). Data are pooled from 2 (HC), 7 (ES), 3 (NS), 2 (primed CD8 Sp), 3 (na€ıve CD8+ T)
or 5 (primed CD8+ T) mice. 13–104 PCV from at least 2 independent experiments. NS is one experiment. (i) Length of PVM abutting PCV
(n = 4), 2 independent experiments.
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Figure 5. PVMs create activity hotspots for CD8+ T cells. (a) Confocal microscopy shows a maximum intensity z-projection of blood vessels of the
brain of PbA-infected DPE-GFP mice during ES. Scale bar: 470 lm. One of two independent experiments (n = 2). (b, c) 2P-IVM of the cerebral
vasculature of PbA-infected DPE-GFP and DPE-GFPxRAG-1/ mice that received primed CD8+ T cells. No accumulation and accumulation were
defined as 0 (grey) or > 0 (black) mm2 min1 respectively. Bars represent mean  SEM. 81–134 blood vessels assessed from 5 (DPE-GFPxRAG-1/)
or 8 (DPE-GFP) mice/group from 3 independent experiments. (d) Representative maximum intensity z-projections (panels 1, 2 and 3) and 3-D
reconstruction (panel 4) of activated hotspots in PbA-infected DPE-GFP mice using confocal microscopy. WGAhi monocytes are indicated by green
arrows, CD8+ T cells by white, vessel wall by white lines, and PVMs (asterisk) are F4/80+ (green-blue) containing intracytoplasmic phagosomes (pink)
(n = 3). Scale bar 18 lm except 3D reconstruction, which is 100 lm. (e) Correlation of the number of PVM clusters with accumulated CD8+ T cells in
DPE-GFP mice (n = 13) (r = 0.62, ****P < 0.0001, Pearson’s test). d and e are from 2 or 7 independent experiments.
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cells and PVM because of overlap of GFP signals.
It was therefore not possible to distinguish
potential trans-endothelial membrane in our
setting. Of note, T-cell co-localisation at PVM sites
was specific as Plasmodium antigen expression in
itself did not support PVM-T cell interactions
(Figure 3f). Collectively, our study identifies
‘activity hotspots’ in PCV marked by increased
number, perivascular clustering, abutting and
activated morphology of PVM that co-localise
with Plasmodium-specific polyclonal CD8+ T cells.
Reduced interaction times between CD8+ T
cells and PVM during NS
Finally, we compared the behaviour of CD8+ T
cells during ES and NS. Crawling T cells travelled
longer distances within a given observation
period during NS (ES, 39.8  11.0 µm min1 vs.
NS, 147.6  12.6 µm min1) (****P < 0.0001)
(Supplementary figure 3a–e, Supplementary video
7). A sharp increase in median instantaneous
velocity (ES, 0 vs. NS, 3.2) reduced the average
migration time along the vessel wall (ES,
169.8  24.6 µm s1 vs. NS, 27.8  3.4 µm s1)
(Figure 6a, b). Furthermore, CD8+ T-cell activity
was no longer restricted to ‘hotspots’ and
involved the entire PCV. Unlike ES, half the cells
that were crawling migrated in loops during NS,
at a sharper turning angle (median turning angle:
ES, 59.6 vs. NS, 124.3) (Figures 6c and
Supplementary figure 3f, g). These changes in
locomotion increased the interaction frequency at
PVM sites (number of interactions per mm2 min1)
during NS (NS, 231.1  34 mm2 min1) as
compared to ES (DPE-GFP mice, 88.9  16 mm2
min1; DPE-GFPxRAG-1/ mice, 38.4  7 mm2
min1) (Figure 6d; Supplementary video 7). PVM
interactions were not a non-specific by-product of
neuroinflammation (Supplementary figure 3h). In
addition, an increasing number of T cells also
began to appear in the extravascular space at this
stage.21 These data suggest that intravascular
PVM-T cell interactions may be important during
early stages of ECM but are less critical once
substantial inflammation is established.
DISCUSSION
The sequence of inflammatory events within the
vasculature during ECM remains incompletely
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Figure 6. Intensified crawling of CD8+ T cells leads to increased engagement with PVM sites. (a) Relative frequency distribution of the
instantaneous velocity of crawling T cells. 31–81 cell tracks from 2 or 3 mice, ****P < 0.0001 (Mann–Whitney U-test). (b) Duration of
intraluminal crawling. Crawlers were tracked after they entered and until they exited from the field of view for a maximum of 10 min of
observation period. 41–96 cell tracks from 3 or 5 mice. Bar indicates mean, ****P < 0.0001 (Mann–Whitney U-test). (c) Relative frequency
distribution of turning angles of crawling T cells. 37–87 cell tracks from 3 or 4 mice, ****P < 0.0001 (Mann–Whitney U-test). a–c are from at
least 2 (ES) or a single experiment (NS). (d) Average number of CD8+ T-cell–PVM interactions (ANOVA, Dunn’s test) during various stages of
disease, HC (n = 2), ES (n = 8), NS (n = 4), primed CD8 Sp (n = 2), na€ıve CD8+ T (n = 3) and primed CD8+ T (n = 5). 18–155 PCVs from 2 or 3
independent experiments/group.
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induction of ECM in the PbA infection model, the
present report focused on the behaviour of CD8+
T cells in the vasculature during both ES and
NS.11,54 Minor clinical signs are not unlike malarial
symptoms in humans (such as shaking chills) and
are primarily a manifestation of parasite release
into the bloodstream.55,56 We have shown here
that CD8+ T cells with antigen specificity for
Plasmodium enter the brain during ES. Upon
entry into the CNS vasculature, they arrest on the
post-capillary venular endothelium adjacent to
PVM. Parasite-specific CD8+ T cells arresting to the
luminal wall in a cognate peptide–MHC I-
dependent manner have been reported; however,
these studies were carried out in mice with fatal
disease.13 Our studies concur with this report as
we detected a significant number of CD8+ T cells
arresting to the luminal wall during NS. Together,
these studies support the idea that retention of
CD8+ T cells recognising cognate antigen in the
brain is favored over those that recognise
irrelevant antigen.57 However, Swanson and co-
authors did not utilise reporter mice that reveal
CNS-resident APC in their studies, making it
impossible to visualise T-cell localisation with
PVM. This is surprising as Shaw et al. have shown
earlier that CX3CR1
+ APCs make cognate
interactions with CD8+ T cells in the perivascular
space in the late stages of ECM.21 In the present
study, we used DPE-GFP reporter mice to visualise
PVM activity in the brain. We found that,
unexpectedly, effector T cells had localised at
activity hotspots characterised by activated
morphology, as well as increased clustering and
abutting of PCV by PVM. Thus, PVM created a
niche for T-cell arrest. At approximately 24–48 h
after localisation at activity hotspots, CD8+ T cells
increased in number, crawled intensely along the
endothelium, increased their interaction rate at
PVM sites and induced NS in mice. Such
intensified T-cell activity within the CNS
vasculature may be necessary for extravasation, as
the BBB is generally considered to shield the brain
and spinal cord from leucocyte access.
Nevertheless, the remarkable transformation in T-
cell behaviour across the disease stages of ECM
raised the question about the role of PVM in
transportation of antigenic cargo across the BBB.
The ability of PVM to present antigen is a well-
described phenomenon.58 For example, in EAE
this occurs after T cells cross the endothelial
barrier and invade the surrounding meningeal/
perivascular space in order to access antigen.
However, the data presented here challenge this
model and instead point to PVM acting as a
conduit for communicating with T cells across the
BBB by releasing signalling mediators such as
chemokines. Furthermore, macrophage/myeloid
cell processes extending through intercellular
junctions of the endothelium in the dermal
vasculature, mesentery and brain as well as
epithelial barriers of the intestinal tract have been
reported.31–33,59 Although the microenvironment
encountered by T cells within the vascular lumen
during ECM will be different from that
encountered in the brain during EAE, our findings
provide a lead for investigating how T cells may
be activated by perivascular APC in the absence of
BBB breach. In this regard, using differential
thresholds of GFP expression to distinguish GFPlo
Plasmodium parasites12 from GFPhi PVM, we were
able to detect phagocytised parasites in PVM
during NS.13 Intracytoplasmic dextran+
phagosomes were also detected, as reported.31
Although this does not directly prove active
plasma sampling, as transport of dextran across
the endothelium into the perivascular space
cannot be excluded in this setting, these data
nevertheless show that PVM can access blood-
borne mediators and/or parasitised red blood cells
(pRBCs).13,60
Another important question relates to the
mechanisms that underlie the attraction of T cells
towards PVM. Only Plasmodium-specific but not
ovalbumin (OVA)-specific CD8+ T cells crawled
along the endothelium and displayed directed
migration towards PVM. Since PVM supposedly
reside behind the BBB, this raises the question as
to how these T-cell alignments may be
established. Firstly, it is possible that early
inflammation causes disruption of the endothelial
monolayer, giving T cells access to the perivascular
space. Secondly, it is conceivable that PVMs
communicate with the vascular lumen across the
endothelium by producing neutrophil-attracting
chemokines.45 We therefore speculate that early
systemic pro-inflammatory signals during ECMs,
such as IFN-c released by NK cells61 and CD4+ T
cells,54 may activate chemokine production by
CNS-resident PVM and lead to subsequent CD8+ T-
cell recruitment.21
Previous evidence, mostly based on in vitro
studies, has suggested that antigen presentation
to Plasmodium-specific CD8+ T cells in the CNS
occurs on cerebral endothelium.62,63 However, this
notion has been contradicted by in vivo studies,
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which found no evidence of endothelial injury,
loss of cell viability or discontinuities in the
vascular lining during ECM.16,21 Recently, MHC I-
deficient Kb/Db/ bone marrow chimeras were
used to show that lack of MHC I-mediated
cognate antigen presentation reduces CD8+ T-cell
arrest in the vasculature and protects mice from
ECM.13 As the vascular lumen is not known to
harbour radioresistant cells, an assumption was
made that reduced CD8+ T-cell arrest in the
vasculature was a direct outcome of poor antigen
presentation by EC. More studies are needed to
corroborate these findings as fate-mapping
studies have revealed that PVMs are long-lived
radioresistant cells of the CNS that develop
independently of Flt3+ haematopoietic
precursors.33,64 Finally, if indeed ECs were
presenting antigen to CD8+ T cells, then the
question arises as to why they do not become
self-targets of cytotoxicity and escape injury.13 We
therefore propose a mechanism similar to that
proposed by Geissmann and co-workers that PVM
and endothelial cells are integral parts of a single
anatomical and functional unit that monitors
trans-endothelial transport and scavenges
particulate matter in the vasculature.34 Thus,
repeated interactions of CD8+ T cells at PVM
sites,31 if they are indeed antigen-specific, result
in the release of cytotoxic mediators, such as
perforin and granzyme B, which would
accumulate at endothelial intercellular junctions
over time and lead to BBB disruption.65 Such
disruptions cause controlled opening of
transcellular and paracellular fluid transport
pathways.16,66 In addition, T cells frantically
migrating along the endothelium may be trying
to find a suitable spot for extravasation. 23 In this
context, it is relevant that granzyme B promotes
CTL extravasation via basement membrane
remodelling.67
Depletion of myeloid cells, for example by
clodronate liposomes (CL) on days 5–7 p.i. or
utilising the CX3CR1-iDTR mice, does not confer
protection from ECM,17,68–70 which may argue
against the role of PVM in this disease. However,
it was unclear from these studies whether
complete PVM depletion had been accomplished
especially since PVMs have a heterogeneous
phenotype.31,45 In addition, in our hands CL
injection intrathecally, as was done in some of
these studies, induces vigorous local inflammation
in the brain resulting in the recruitment of
neutrophils and monocytes. This is not surprising
as macrophage depletion leads to disruption of
EC junctions and increases vascular permeability.32
In the light of this, there is the need for more
specific depletion approaches for PVM to dissect
their precise role in ECM.
Collectively, we propose that CD8+ T cells
localise specifically at PVM hotspots in the early
phases of ECM development. Such encounters
may provide an instruction for T cells to
reactivate, and produce cytokines and cytotoxic
mediators, which consequently amplifies the
inflammatory response within the CNS
vasculature.18,19,71,72 This idea is supported by
straighter T-cell trajectories leading to increased
interaction rate at PVM sites during NS, consistent
with the notion that chemotactic ‘roadmaps’ laid
along the endothelium by previous cells guide
new ‘recruits’ more efficiently to their target
cell.73 Therefore, a better understanding of the
nature of T-cell–PVM interactions may provide a
therapeutic target for this devastating condition.
METHODS
Mice
All mice used in this study were on a C57BL/6 background.
mT/mG mice were purchased from the Jackson Laboratory.74
DPE-GFP mice were described previously.44 C57BL/6 and RAG-
1/ mice were obtained from the Australian Resources
Centre (Perth, Australia). DPE-GFPxRAG-1/ mice were
screened for GFP+, CD3+ and B220+ expression by flow
cytometry and RAG-1 gene expression by RT-PCR. Only
CD3GFP+ DPE-GFPxRAG-1/ mice were used. This study was
carried out in accordance with the guidelines from the
National Health and Medical Research Council of Australia.
All animal procedures and protocols were approved by the
University of Sydney Animal Ethics Committee. All mice were
maintained with environmental enrichment in specific
pathogen-free (SPF) conditions at the Centenary Institute
Animal Facility or the Medical Foundation Building Animal
Facility, Department of Pathology, University of Sydney. The
surgical procedures and intravital imaging were performed
by trained specialists as described.43
Parasites and infections
The maintenance and usage of PbA strain were described
previously.75 Mice were infected with PbA by
intraperitoneal injection (i.p.) of 106 pRBC. Parasitaemia
was monitored by examining Diff-Quick-stained (Lab Aids,
Narrabeen, NSW, Australia) thin blood smears prepared
from tail bleeds. Other read-outs included hepatomegaly,
splenomegaly, enlarged lymph nodes and haemozoin
pigmentation during dissections. SIINFEKL/GFP-expressing
PbA (PbTG) and GFP-expressing PbA (PbG) were a kind gift
from Dr William Heath (University of Melbourne).
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Clinical disease assessment
PbA-infected mice were monitored for up to and including
day 7 p.i. as reported.17 From days 1 to 6 p.i., mice were
assessed for minor clinical signs such as reduced activity,
hair standing on end, prominent vertebral spinous
processes/scapulae/pelvis, sunken eyes and/or hunched
posture. Mice showing these minor clinical signs were
referred to as being in ES. Each sign was given a score of 1.
Mice developing ≥ 3 signs on days 1-6 p.i. were euthanised
in accordance with ethics guidelines. Otherwise, mice
progressed to day 7 p.i. On day 7 p.i., mice were assessed
for clinical signs of illness including reduced searching
behaviour, hypothermia, ruffled fur, isolation from group
and/or partial immobility, as well as loss of motor response
including ataxia, muscular weakness, inability to grab the
cage grid, inability to hold on to a rope and/or tendency to
fit upon manipulation. Initially, mice exhibited clinical signs
of illness and then progressed to show loss of motor
response. Mice showing loss of motor responses were
referred to as being in NS. Mice were given a score of 1 for
each sign. Mice selected for intravital imaging showed no
more than 4 signs indicating loss of motor response. All
mice in the experimental study were euthanised on day 7
p.i. with the exception of some mice that showed no
clinical signs, which were monitored for up to and
including day 8 p.i. PbTG/PbG-infected mice were
monitored for up to and including day 10 p.i.
Flow cytometry
The method for preparation of BSL for flow cytometry has
been reported.17 Mice were sacrificed and perfused via the
heart with 20 mL of perfusion fluid to remove blood
contaminants from the cerebral vasculature. Brains were
mashed between frosted glass slides in PBS and digested
with collagenase type IV (Sigma, St. Louis, Missouri, USA)
and DNase I (Sigma). Low-density dead cells/debris/myelin
were removed by resuspension in 30% Percoll followed by
centrifugation. Cells obtained from the brain were
suspended in 2% (v/v) FCS in PBS containing anti-CD16/32
(2.4G2) (BD, New Jersey, USA) to block Fc receptors. Cells
were labelled by incubating with fluorochrome-labelled
antibodies (see Supplementary table 1) diluted in FACS
buffer for 30 min on ice after which cells were washed and
stained with 0.5 lg mL1 DAPI (Invitrogen, Carlsbad,
California, USA) for dead cell exclusion. Data were acquired
on a FACSCanto II (BD), LSRFortessa (BD) or LSR-II flow
cytometer (BD) and analysed using FlowJo software
(Treestar, Ashland, Oregon, USA).
Immunohistochemistry
Mice were euthanised and perfused with 10% neutral
buffered formalin in PBS. Brains were harvested and further
fixed in 10% neutral buffered formalin (Sigma) and 4% w/v
sucrose overnight at 4°C. Using a vibratome, longitudinal or
superior transverse sections were prepared and blocked in
10% FCS. For some experiments, mice were injected WGA-
A594 (Life Technologies, Carlsbad, California, USA) i.v. prior
to sacrifice to reveal blood vessels. In others, brain sections
were stained with anti-CD31 antibody (BD). Staining blood
vessels with WGA prior to anti-CD31 antibody treatment
caused differential staining with PCV revealing as
CD31+WGAlo and arterioles as WGA+CD31lo. Stained sections
were mounted in Dako mounting medium. A series of
single Z-stack images were acquired at 1-lm interval
through a volume of 1000 lm using either a 209 or 639 oil
objective of the Leica SP5 confocal microscope.
Fluorochrome-labelled antibodies used for
immunohistochemistry are described in Supplementary
table 1.
Cranial window preparation
A detailed protocol for the preparation of mice for 2P-IVM
has been previously published.43 Briefly, mice were closely
monitored for awareness signs and surgical procedures
were initiated only after the animal entered a deep state of
anaesthesia.17 Anaesthetised mice were placed on a heat
pad (Fine Science Tools, Foster City, California, USA), and
core body temperature was monitored using a rectal probe
(Fine Science Tools). The head of the mouse was restrained
in a stereotaxic frame, and a circular incision was made in
the parietal bone using a pneumatic dental drill to yield a
cranial flap. The flap was lifted gently without damaging
the dura mater underneath. Minor bleeding was controlled
using gelfoam bits, and the cranial window was bathed in
pre-warmed artificial cerebrospinal fluid. The chamber was
sealed with a coverslip held in place with vacuum grease.
2-Photon intravital microscopy
A detailed protocol has been previously published.43 The
intravital imaging experiments were performed for no
longer than 1.5 h.17,43 Images were acquired using a
LaVision BioTec TrimScope II single-beam 2-photon
microscope (Gottingen, Germany) attached to an Olympus
BX-51 fixed-stage microscope equipped with 209 (NA0.8)
water immersion objective. The set-up included external
non-descanned dual-channel/fluorescence detectors and a
diode-pumped, wide-band mode-locked Ti:sapphire
femtosecond laser (MaiTai HP; Spectra-Physics, 720–
1050 nm, pulse length 140 fs; 90 MHz repetition rate).
TRITC-conjugated dextran (800 lg) (Invitrogen) or Evans
Blue conjugated to BSA was injected i.v. for labelling blood
vessels. The brain was exposed to polarised laser light at a
wavelength of 900 nm. Emitted light was separated with
appropriate filter sets, and four photo-multiplier tubes,
including two ultrasensitive ones, were used for collecting
light. To maximise our observations, we varied the area and
depth of imaging, but x-y-t data were mostly acquired of a
300 lm 9 300 lm plane at a resolution of 0.6 lm pixel1
captured at the rate of 1 frame per second. As the limited
scan speed of a point line scanner as used in our
microscope set-up can be restrictive, this strategy was useful
while tracking leucocytes that roll along the endothelial
wall at 2050 lm s152. A minimum of 120 to maximum
1200 frames were collected and sometimes combined with
3-dimensional z stacks to create x-y-z-t time-lapse images.
For x-y-z-t images, our set-up allowed a maximal
penetration depth of 250 lm of the meningeal and
submeningeal parenchyma. Snapshots of x-y-z stacks were
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acquired at a maximal penetration depth of 1000 lm. For
data acquisition, firstly a suitable field of view was selected
in the upper left region of the cranial window. The next
field of view was recorded by moving horizontally across to
the next 300 lm 9 300 lm plane within the cranial window
as described previously.17,43
Image analysis
Unless otherwise stated, image analysis was done using
VoloCity (Perkin Elmer, Waltham, Massachusetts, USA).
High-resolution 4D x-y-z-t raw data sets from 2P-IVM
experiments were imported into Imaris for 3D rendering
(version 8.1.2; Bitplane, Zurich, Switzerland). Each blood
vessel was initially assessed for intact blood flow, which was
defined by the presence of at least one free-flowing, high-
velocity leucocyte within a blood vessel and its tributaries
for the entire observation period. Blood vessels were
classified based on its (a) blood flow and/or (b) diameter.
Based on (a), diverging vessels with outflow of blood were
classified as arteries and converging vessels with inflow of
blood were classified as veins. Based on (b), blood vessels of
0–8 lm diameter were defined as capillaries and > 8 lm
diameter as arterioles (outflow) or PCV (inflow). PCVs were
further sorted into 8–20 lm, 20–50 lm, 50–100 lm and
100–160 lm diameters. The area of a blood vessel was
measured by multiplying its length and diameter. Abutting
was defined as ≥ 1 PVM lining the length of a blood vessel.
Rolling, crawling and arrested cell behaviour have been
reported elsewhere.50,51,76 Rolling cells were defined as
single, spherical cells moving in the direction of the blood
flow at a lower speed than free-flowing cells. Crawling cells
were defined as single ovoid/elongated cells with a leading
edge and a trailing uropod moving with or against the
blood flow. Single cells that remained stationary for 20 s or
longer were defined as ‘arrested’ cells. Crawling T cells
could be further differentiated from arrested cells by their
motility. The number of leucocytes in the blood vessel was
defined as the average of the total number of rolling,
adherent and crawling cells visualised per mm2 area of
blood vessel per minute. Mean velocity (Vmean) was defined
as the mean distance travelled by leucocytes in the blood
vessel per second. Displacement rate was defined as the
distance between the location of a cell at the start and end
of an observation period of one minute. Meandering index
was defined as displacement of a cell divided by its total
length of track.
Distance between T cells and PVM was measured by
calculating the length in µm between the centre point of a
T cell and the outer perimeter of the nearest PVM. As some
T cells extended pseudopodia rapidly in various directions,
the centre point of a T cell, rather than its perimeter, was
taken as a more reliable reference point for measuring
distance. To calculate length, the body of PVM running
parallel to the horizontal axis of the blood vessel was
measured.
T-cell isolation and adoptive transfer
T-cell isolations were performed as described.17 Cell
isolations were performed in a biological safety cabinet to
facilitate transfer under sterile conditions into
immunodeficient mice. To obtain GFP+CD8+ T cells by
positive selection, splenocytes from DPE-GFP mice were
disaggregated and labelled with CD8-conjugated
immunomagnetic beads (Miltenyi, Bergisch Gladbach,
Germany) and subsequently sorted using a MACS system
(Miltenyi). Further enrichment was achieved by passing the
positive fraction through a second MACS column. Based on
flow cytometry, approximately 92% of the cells in the
positive fraction were CD3+CD8+ T cells, most of which
expressed GFP (Supplementary figure 1c). Approximately
5% CD8+ T cells eluted into the CD8 splenocyte fraction.17
For adoptive transfer experiments, DPE-GFPxRAG-1/
recipient mice 6–8 weeks of age were initially infected i.p.
with 106 pRBC, following which either 5, 10 or 22 9 106
MACS-purified CD8+ T cells or CD8 splenocytes were
adoptively transferred into recipient mice via the tail vein.
Recipient mice were then selected based on disease stage.
For in vitro stimulation of RFP+OT-I cells, 3–5 9 106
splenocytes from mT/mG OT-I mice74 were incubated with
OVA-derived 0.5 lg mL1 SIINFEKL peptide (Auspep,
Tullamarine, VIC, Australia) and 10 ng mL1 rIL-2 in cell
culture medium. After 48 h, cells were transferred to flasks
and rIL-2 was replenished every alternate day. After 6 days
of culture, OT-I CTL cells were 99% pure by flow cytometry.
5 9 106 cells were injected i.v. into PbA-infected mice on
day 2 p.i.
Statistical analysis
Differences in survival of treatment groups were analysed
using the Mantel–Cox log-rank test. Correlations were
calculated and plotted using Prism (GraphPad Prism; San
Diego, California, USA). For comparison of two groups, the
Student’s t-test (normally distributed) or the Mann–Whitney
U-test (not normally distributed) was used. For multiple
comparisons, one-way ANOVA was used. A difference
between groups was considered significant if P < 0.05.
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